Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03814850

Remote Ischemic PreConditioning (RIPC)

Remote Ischemic PreConditioning Provides Neuroprotection: A Phase 2, Single Center, Randomized, Double-Blind, Sham-Controlled, Safety and Efficacy Study Evaluating the Use of Remote Ischemic Preconditioning in Patients Undergoing Endovascular Repair of Brain Aneurysms

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Sebastian Koch · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to learn about protecting the brain from low blood flow (ischemia) with limb preconditioning. From human studies the investigators know that the brain can be protected from dangerous low blood flow by reducing the blood flow to an arm or leg for just a short period of time. This is called limb preconditioning. The investigators are studying the safety and feasibility of preconditioning and their effect of protecting the brain from ischemia in two different groups. This is a Phase 2, randomized, double-blind, sham-controlled, design. Up to 50 male and female patients undergoing elective endovascular repair of unruptured brain aneurysm who are randomized to the remote ischemic preconditioned or sham group will be enrolled. This study consists of one 3-9 month study period for each patient plus up to 14 days for enrollment activities. Subjects are required to return between 3-9 months for end-of-study procedures.

Conditions

Interventions

TypeNameDescription
DEVICEStandard Manual Aneroid SphygmomanometerUse of a standard manual blood pressure cuff and manometer for the conditioning intervention.

Timeline

Start date
2024-12-01
Primary completion
2025-12-31
Completion
2025-12-31
First posted
2019-01-24
Last updated
2023-12-08

Locations

2 sites across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03814850. Inclusion in this directory is not an endorsement.